Flow cytometry crossmatch reactivity with pronase-treated T cells induced by non-HLA autoantibodies in human immunodeficiency virus-infected patients
- 1 June 2016
- journal article
- Published by Elsevier in Human Immunology
- Vol. 77 (6) , 449-455
Abstract
No abstract availableKeywords
Funding Information
- Mayo Clinic
This publication has 25 references indexed in Scilit:
- Frequent False-Positive Reactions in Pronase-Treated T-Cell Flow Cytometric Cross-match TestsTransplantation Proceedings, 2012
- Improved Luminex-based human leukocyte antigen-specific antibody screening using dithiothreitol-treated seraHuman Immunology, 2010
- Improved Graft Survival in Highly Sensitized Patients Undergoing Renal Transplantation After the Introduction of a Clinically Validated Flow Cytometry CrossmatchTransplantation, 2009
- Presence of CD4+CD8+ double‐positive T cells with very high interleukin‐4 production potential in lesional skin of patients with systemic sclerosisArthritis & Rheumatism, 2007
- Pronase treatment facilitates alloantibody flow cytometric and cytotoxic crossmatching in the presence of rituximabHuman Immunology, 2004
- IMPROVED FLOW CYTOMETRIC DETECTION OF HLA ALLOANTIBODIES USING PRONASETransplantation, 2001
- Hyperacute renal allograft rejection from anti-HLA class 1 antibody to B cells -antibody detection by two color FCXM was possible only after using pronase-digested donor lymphocytesTransplant International, 1997
- The use of pronase-digested human leukocytes to improve specificity of the flow cytometric crossmatchTransplant International, 1995
- IMPROVED GRAFT SURVIVAL FOR FLOW CYTOMETRY AND ANTIHUMAN GLOBULIN CROSSMATCH-NEGATIVE RETRANSPLANT RECIPIENTSTransplantation, 1990
- UTILITY OF PROTEASE-DIGESTED HUMAN PERIPHERAL BLOOD LYMPHOCYTES FOR THE DETECTION OF LYMPHOCYTE-REACTIVE ALLOANTIBODIES BY INDIRECT IMMUNOFLUORESCENCE1Transplantation, 1977